A share price of Resmed Inc [RMD] is currently trading at $252.86, up 0.17%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The RMD shares have gain 3.12% over the last week, with a monthly amount drifted -6.37%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Resmed Inc [NYSE: RMD] stock has seen the most recent analyst activity on September 18, 2025, when Citigroup initiated its Buy rating and assigned the stock a price target of $330. Previously, CLSA upgraded its rating to Outperform on September 02, 2025. On July 15, 2025, upgrade upgraded it’s rating to Outperform but maintained its price target of $294 on the stock. Morgan Stanley started tracking the stock assigning a Overweight rating and suggested a price target of $280 on March 19, 2025. Morgan Stanley initiated its recommendation with a Overweight. In a note dated January 10, 2025, Piper Sandler initiated an Neutral rating and provided a target price of $252 on this stock.
Resmed Inc experienced fluctuations in its stock price throughout the past year between $199.92 and $293.81. Currently, Wall Street analysts expect the stock to reach $296 within the next 12 months. Resmed Inc [NYSE: RMD] shares were valued at $252.86 at the most recent close of the market. An investor can expect a potential return of 17.06% based on the average RMD price forecast.
Analyzing the RMD fundamentals
Trailing Twelve Months sales for Resmed Inc [NYSE:RMD] were 5.26B which represents 9.07% growth. Gross Profit Margin for this corporation currently stands at 0.6% with Operating Profit Margin at 0.33%, Pretax Profit Margin comes in at 0.33%, and Net Profit Margin reading is 0.27%. To continue investigating profitability, this company’s Return on Assets is posted at 0.17, Equity is 0.25 and Total Capital is 0.25. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.14.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 250.75 points at the first support level, and at 248.63 for the second support level. However, for the 1st resistance point, the stock is sitting at 255.49, and for the 2nd resistance point, it is at 258.11.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Resmed Inc [NYSE:RMD] is 2.89. In addition, the Quick Ratio stands at 2.13 and the Cash Ratio stands at 1.1. Considering the valuation of this stock, the price to sales ratio is 7.02, the price to book ratio is 6.03 and price to earnings (TTM) ratio is 25.88.
Transactions by insiders
Recent insider trading involved Peter C Farrell, Director, that happened on Nov 12 ’25 when 2000.0 shares were purchased. Director, De Witte Jan completed a deal on Nov 11 ’25 to buy 487.0 shares. Meanwhile, Chairman and CEO Farrell Michael J. sold 8011.0 shares on Nov 07 ’25.
